Want to see DE:ILM1 full AI Analyst Report?
ILM1 Stock Chart & Stats
€13.34
-€0.40(-3.02%)
At close: 4:00 PM EST
€13.34
-€0.40(-3.02%)
Day’s Range― - ―
52-Week Range€11.64 - €17.44
Previous CloseN/A
Volume6.65K
Average Volume (3M)45.28K
Market Cap
€312.19M
Enterprise Value€434.27M
Total Cash (Recent Filing)€92.85M
Total Debt (Recent Filing)€202.69M
Price to Earnings (P/E)22.3
Beta0.96
Next Earnings
Aug 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.55
Shares Outstanding25,505,724
10 Day Avg. Volume55,289
30 Day Avg. Volume45,276
Financial Highlights & Ratios
PEG Ratio1.21
Price to Book (P/B)0.71
Price to Sales (P/S)0.17
P/FCF Ratio9.82
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€22.00Price Target Upside64.92% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)1.39
Revenue Forecast (FY)€2.10B
Bulls Say, Bears Say
Bulls Say
International ExpansionThe internationalisation strategy of Medios is showing promising results with the successful integration of the Ceban acquisition.
Regulatory EnvironmentHigher profitability appears sustainable due to a more liberal regulatory framework in the Netherlands, giving the company greater entrepreneurial freedom.
Bears Say
Earnings ForecastHigher M&A-related one-offs, increased depreciation, and a higher tax rate have resulted in a lower EPS forecast.
Medios AG News
ILM1 FAQ
What was Medios AG’s price range in the past 12 months?
Medios AG lowest stock price was €11.64 and its highest was €17.44 in the past 12 months.
What is Medios AG’s market cap?
Medios AG’s market cap is €312.19M.
When is Medios AG’s upcoming earnings report date?
Medios AG’s upcoming earnings report date is Aug 12, 2026 which is in 40 days.
How were Medios AG’s earnings last quarter?
Medios AG released its earnings results on May 12, 2026. The company reported €0.44 earnings per share for the quarter, beating the consensus estimate of €0.22 by €0.22.
Is Medios AG overvalued?
According to Wall Street analysts Medios AG’s price is currently Undervalued.
Does Medios AG pay dividends?
Medios AG does not currently pay dividends.
What is Medios AG’s EPS estimate?
Medios AG’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Medios AG have?
Medios AG has 25,505,724 shares outstanding.
What happened to Medios AG’s price movement after its last earnings report?
Medios AG reported an EPS of €0.44 in its last earnings report, beating expectations of €0.22. Following the earnings report the stock price went down -13.514%.
Which hedge fund is a major shareholder of Medios AG?
Currently, no hedge funds are holding shares in DE:ILM1
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Medios AG Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-9.08%
12-Months-Change
Fundamentals
Return on Equity
2.69%
Trailing 12-Months
Asset Growth
5.41%
Trailing 12-Months
Company Description
Medios AG
Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment also includes cytostatic preparations, antibody therapies, and parenteral nutrition solutions. The International Business International covers all activities in the international environment from the procurement of Active Pharmaceutical Ingredients, the sterile and non-sterile drugs and the supply of public and hospital pharmacies through homecare service. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. Medios AG is founded in 2015 and was headquartered in Berlin, Germany.
ILM1 Company Deck
ILM1 Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a positive sentiment with strong financial performance and strategic advancements, despite some challenges in specific segments and increased costs related to acquisitions.View all DE:ILM1 earnings summariesILM1 Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
€22.00
▲(64.92% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month
MATERNUS-Kliniken AG
―
Limes Schlosskliniken AG
―
Eifelhoehen-Klinik AG
―
Gesundheitswelt Chiemgau AG
―
M1 Kliniken AG
―
Options Prices
Currently, No data available
---






